Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1508.6000 31.50 (2.13%)
NSE Oct 16, 2026 15:31 PM
Volume: 213.0K
 

1508.60
2.13%

Four straight post-IPO beats; execution remains stellar

Motilal Oswal
Rubicon Research (RUBICON) delivered its fourth consecutive earnings surprise since its IPO (4%/13%/16% beat on revenue/EBITDA/PAT)—a strong pattern of promise vs consistent superior execution.
Rubicon Research has gained 73.28% in the last 6 Months
More from Rubicon Research Ltd.
All Rapid Results
Recommended